Ceva Completes Deal to Acquire Portfolio of Merial Swine and Cattle Vaccines and Nonsteroidal Anti-inflammatories from Boehringer Ingelheim

Food and Healthcare Press Releases Friday January 20, 2017 10:34
LIBOURNE, France--20 Jan--PRNewswire/InfoQuest

Ceva Sante Animale today completed the acquisition of a diversified portfolio of products, including swine and cattle vaccines and multi-species nonsteroidal anti-inflammatories from Boehringer Ingelheim following its acquisition of Merial Animal Health.

All the products will be immediately available through local Ceva companies or its distributors, with no interruption of supply.
Ceva has been consistently one of the fastest growing top 10 veterinary businesses in the last decade, investing heavily in the development of vaccines, as part of its global preventative health strategy.
Commenting on the deal, Ceva Chairman & CEO Dr. Marc Prikazsky said:

"We are delighted to acquire this range of products and strong pipeline of R&D assets.   The knowhow behind these products dates from Pasteur, Rhone-Merieux, Merial and now as Ceva we are conscious that we have a responsibility to maintain this strong veterinary scientific tradition.   Our customers can be assured that we will continue to invest to develop the products of both today and tomorrow."

ABOUT CEVA SANTE ANIMALE

Ceva Sante Animale was founded in 1999 and is a global veterinary health company, focused on research, development, production and marketing of pharmaceutical products and vaccines for companion animals, livestock, swine and poultry. Its headquarters are in Libourne (Gironde). Ceva Chairman and CEO is Marc Prikazsky.

Website: http://www.ceva.com
PRESS CONTACT
Martin Mitchell
Communication Director
+33-05-57-55-40-80
martin.mitchell@ceva.com
Company: Davidson Ryan Dore
Lawrence Dore
Lawrence.dore@drdpartnership.com
Phone: +44(0)207-520-9218
Source: Ceva Sante Animale

Latest Press Release

CLJI Worldwide Trial Enrolls First Patient in Clinical Study Evaluating the Performance of VIBLOK as a Barrier for Herpes Simplex Virus Transmission in Men and Women

CLJI Worldwide Sponsored Study Assessing the Safety and Performance of VIBLOK in HSV-2 infected adults as a barrier for virus transmission; Principal Investigators Named; First Patient Enrolled CLJI Worldwide reports the start of the VIBLOK Safety And...

Leica Biosystems Aperio Digital Pathology Now Nationwide Standard of Care in Kuwait*

Leica Biosystems announced today that it has struck a key partnership with the Kuwait Ministry of Health, through its distributor, Technical Services Supplies Trading & Contracting Company, W.L.L. The Pathology Council of Kuwait will now adopt Leica...

#Its not you. Its your thyroid. Campaign Launched to Raise Awareness of Symptoms

The information contained in this release is not appropriate for audiences in the USA and Canada. - International survey reveals that almost a third of women could not explain what thyroid disorders are - Most respondents were unaware that symptoms...

100 Healthy Years Are Kids Prepared?

- Merck Consumer Health's Annual Debate: global expert discussion on how to prepare children to live 100 healthy years - Global study of the Economist Intelligence Unit: today's children will be less healthy than today's adults over 65 when they reach...

Healthcare Industry Springs to Life at the World#s Largest Healthcare Event - The Health Industry Summit (tHIS)

The Health Industry Summit (tHIS) 2017 hosted by China and organized by Reed Sinopharm, opened in Shanghai at the National Exhibition and Convention Center on May 15th with hundreds of thousands of healthcare industry professionals from more than 150...

Related Topics